PeterT.PistersMD

General Surgery • Houston, TX

Surgical Oncology (Other than Breast)

Professor of Surgery, University Tex Houston

Join to view full profile

Dr. Pisters is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pisters' full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6000

Education & Training

Harvard School of Public HealthMS, Healthcare Management, 2012 - 2014
NYU Grossman School of MedicineResidency, Surgery, 1985 - 1992
University of Western OntarioClass of 1985

Certifications & Licensure

TX State Medical License 1994 - 2026
American Board of Surgery Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Top Doctors:SE Texas Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Fellow American College of Surgeons
Join now to see all

Clinical Trials

Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma Start of enrollment: 1998 Mar 01
Completed
Phase 1
Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma Start of enrollment: 1997 Jul 01
Completed
Phase 1
Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
Withdrawn
Phase 2
Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer Start of enrollment: 2002 May 01
Completed
Phase 2
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis Start of enrollment: 2004 Aug 01
Completed
Phase 3
Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma Start of enrollment: 2003 Jan 01
Completed
Phase 1
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Start of enrollment: 2009 Apr 01
Completed
Phase 2
PP-Gemcitabine & External Beam Radiation-Sarcomas Start of enrollment: 2001 Dec 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Impact of Cancer Care Regionalization on Patient Volume.
Kevin J Contrera, Samantha Tam, Kristen Pytynia, Eduardo M Diaz Jr, Amy C Hessel
Annals of Surgical Oncology. 2023-04-01
ASO Visual Abstract: Impact of Cancer Care Regionalization on Patient Volume.
Kevin J Contrera, Samantha Tam, Kristen Pytynia, Eduardo M Diaz Jr, Amy C Hessel
Annals of Surgical Oncology. 2023-04-01
10 citations
Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis.
David Hui, Nico Nortje, Marina George, Kaycee Wilson, Diana L Urbauer
Journal of Clinical Oncology. 2023-01-20

Press Mentions

MD Anderson Launches New Institute for Advancing Cell TherapyNovember 7th, 2024
Cancer Care Is Getting Personal. Local Doctors Can’t Keep Up.October 26th, 2024
MD Anderson Expands Arts Experience Program to Enhance Healing and Well-Being for PatientsOctober 23rd, 2024
Join now to see all